{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:50:14Z","timestamp":1768852214362,"version":"3.49.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>Pancreatogenic diabetes is a frequent and often underestimated consequence of acute and chronic pancreatitis. This form of diabetes shows clinical characteristics intermediate between type 2 and type 1 diabetes, presenting both insulin resistance and an insulin secretory defect that often requires earlier initiation of insulin therapy. We describe the case of a 60-year-old man with a history of obesity and family predisposition to diabetes who developed diabetes after necrotizing hemorrhagic acute pancreatitis complicated by portal vein thrombosis. The patient expressed great concern about his persistent hyperglycemia and marked glucose variability. Despite intensive treatment with oral antihyperglycemic agents and a basal-bolus insulin regimen, glycemic control remained suboptimal and characterized by wide fluctuations. Given the very high basal-to-bolus insulin ratio and the need for dynamic insulin delivery, the mylife Loop insulin delivery system was initiated. This resulted in a rapid and sustained improvement of glycemic control, with the Time in Range (TIR) increasing from 43% to 72% after one month and up to 88% at three months, while the Glucose Management Indicator (GMI) decreased from 7.9% to 6.5%. Benefits were stable at six months. To our knowledge, this is the first report describing the use of hybrid closed-loop insulin delivery system in diabetes following pancreatitis, and highlights how this technology can be particularly useful in achieving optimal glycemic control in patients in whom oral therapy is insufficient and conventional basal-bolus regimens are limited by the inability to personalize insulin delivery throughout the day. Automated insulin delivery proved effective in addressing the peculiar challenges of pancreatogenic diabetes, including high glycemic variability and a more complex management of prandial insulin therapy.<\/jats:p>","DOI":"10.3389\/fcdhc.2025.1747454","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:28:01Z","timestamp":1768800481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of hybrid closed-loop insulin pump in pancreatogenic diabetes following necrotizing hemorrhagic pancreatitis: a case report"],"prefix":"10.3389","volume":"6","author":[{"given":"Laura","family":"Soldovieri","sequence":"first","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gea","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Brunetti","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Di Giuseppe","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Gentile","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Sofia","family":"De Lucia","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Pancreas Unit, Digestive Disease Center in the affiliation (CEMAD) Unit, Digestive Disease Center, Fondazione Policlinico Universitario A. Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Pancreas Unit, Digestive Disease Center in the affiliation (CEMAD) Unit, Digestive Disease Center, Fondazione Policlinico Universitario A. Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giaccari","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico Celestino","family":"Nista","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Pancreas Unit, Digestive Disease Center in the affiliation (CEMAD) Unit, Digestive Disease Center, Fondazione Policlinico Universitario A. Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Mezza","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]},{"name":"Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001359","article-title":"New-onset diabetes mellitus after chronic pancreatitis diagnosis: A systematic review and meta-analysis","volume":"48","author":"Zhu","year":"2019","journal-title":"Pancreas"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000756","article-title":"Diabetes in chronic pancreatitis: risk factors and natural history","volume":"37","author":"Goodarzi","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70093","article-title":"Incretin system and glucagon secretion in patients with chronic pancreatitis","volume":"55","author":"Ciccarelli","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00019-4","article-title":"Diabetes following acute pancreatitis","volume":"6","author":"Hart","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/MPA.0000000000001818","article-title":"Identification of a risk profile for new-onset diabetes after acute pancreatitis","volume":"50","author":"Firkins","year":"2021","journal-title":"Pancreas"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2024.06.007","article-title":"Beta-cell function and glucose metabolism in patients with chronic pancreatitis","volume":"128","author":"Ciccarelli","year":"2024","journal-title":"Eur J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i31.4736","article-title":"Diabetes as a consequence of acute pancreatitis","volume":"29","author":"Charley","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000564","article-title":"The long-term prospective follow-up of pancreatic function after the first episode of acute alcoholic pancreatitis: recurrence predisposes one to pancreatic dysfunction and pancreatogenic diabetes","volume":"51","author":"Nikkola","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19322968251356239","DOI":"10.1177\/19322968251356239","article-title":"Increased glycemic variability in patients with chronic pancreatitis and diabetes compared to type 2 diabetes","author":"Davidsen","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2024.0130","article-title":"Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"49","author":"Fan","year":"2025","journal-title":"Diabetes Metab J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S007","article-title":"Diabetes technology: standards of care in diabetes\u20142025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70150","article-title":"Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials","volume":"2025","author":"Di Molfetta","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.diabet.2024.101544","article-title":"Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series","volume":"50","author":"Touimer","year":"2024","journal-title":"Diabetes Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30061-0","article-title":"Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial","volume":"7","author":"Boughton","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18233","article-title":"Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2024.06.015","article-title":"Pancreatitis and pancreatic cancer risk among patients with type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors: an updated meta-analysis of randomized controlled trials","volume":"46","author":"Tuersun","year":"2024","journal-title":"Clin Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"107981","DOI":"10.1016\/j.diabres.2019.107981","article-title":"Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials","volume":"159","author":"Dicembrini","year":"2020","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1747454\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:28:02Z","timestamp":1768800482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1747454\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":17,"alternative-id":["10.3389\/fcdhc.2025.1747454"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2025.1747454","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"article-number":"1747454"}}